{"id":8210,"date":"2021-03-04T10:59:23","date_gmt":"2021-03-04T10:59:23","guid":{"rendered":"https:\/\/thepublicationplan.com\/?p=8210"},"modified":"2021-03-31T08:46:45","modified_gmt":"2021-03-31T08:46:45","slug":"research-integrity-across-the-atlantic-our-summary-of-the-first-biomedical-transparency-summit-series-webinar","status":"publish","type":"post","link":"https:\/\/thepublicationplan.com\/2021\/03\/04\/research-integrity-across-the-atlantic-our-summary-of-the-first-biomedical-transparency-summit-series-webinar\/","title":{"rendered":"Research integrity across the Atlantic: our summary of the first Biomedical Transparency Summit series webinar"},"content":{"rendered":"

\"\"<\/p>\n

Last week, the Center for Biomedical Research Transparency (CBMRT<\/a>) hosted the first of three webinars forming this year\u2019s virtual Biomedical Transparency Summit series<\/a>. The webinar, entitled \u2018Research integrity \u2013 developments across the Atlantic<\/em>\u2019, was opened by the CBMRT\u2019s CEO Sandra Petty (recently interviewed by The Publication Plan<\/a>) and speakers included Professor Ana Maru\u0161i\u0107<\/a> (Standard Operating Procedures for Research Integrity [SOPs4RI<\/a>]) and Dr Michael Lauer<\/a> (National Institutes of Health [NIH]).<\/p>\n

Professor Maru\u0161i\u0107 spoke about the importance of research ethics and integrity, which together contribute to \u2018responsible research\u2019. She also shared the ongoing efforts to develop the SOPs4RI toolbox<\/a>, funded by the European Commission, which aims to assist research-performing and funding organisations to promote research integrity. SOPs4RI have found that few data exist<\/a> about how institutions can effectively improve research culture, but have also identified many potential actions<\/a> that can be taken.<\/p>\n

While highlighting diverse examples of research misconduct, Dr Lauer discussed the different stakeholders responsible for ensuring research integrity and discouraging misconduct, emphasising that everyone plays a role. He noted that the NIH have previously clarified<\/a> that institutions receiving funding are responsible for ensuring that their employees (and final funding recipients) adhere to research best practices, such as disclosing conflicts of interest and preventing issues like falsification of data and plagiarism.<\/p>\n

Further topics of discussion included:<\/p>\n